JP Patent

JP4373983B2 — 流通経路管理装置及び流通経路管理プログラム

Assigned to Mitsubishi Electric Information Systems Corp · Expires 2009-11-25 · 16y expired

What this patent protects

Patent listed against Abilify.

Drugs covered by this patent

Abilify (aripiprazole) · Generic (originally Otsuka/BMS)

Patent Metadata

Patent number: JP4373983B2
Jurisdiction: JP
Classification: —
Expires: 2009-11-25
Drug substance claim: No
Drug product claim: No
Assignee: Mitsubishi Electric Information Systems Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.